50764-07-3 (（2S，3R，4S）-4-羟基异亮氨酸,(2S,3R,4S)-4-Hydroxyisoleucine)

快速询单

结构式：

（2S，3R，4S）-4-羟基异亮氨酸MOL文件

CAS号：

50764-07-3

中文名称：

（2S，3R，4S）-4-羟基异亮氨酸

英文名称：

(2S,3R,4S)-4-Hydroxyisoleucine

分子式：

C₆H₁₃NO₃

分子量：

147.172322034836

（2S，3R，4S）-4-羟基异亮氨酸(50764-07-3)名称与标识符

名称

英文别名：

(2S,3R,4S)-4-Hydroxyisoleucine;

标识符

InChIKey：

OSCCDBFHNMXNME-UHFFFAOYSA-N

Inchi：

1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)

SMILES：

CC(C(C(C(=O)O)N)C)O

（2S，3R，4S）-4-羟基异亮氨酸(50764-07-3)相关文献

1. Stereocontrolled routes to β,β′-disubstituted α-amino acids
Julien Michaux,Gilles Niel,Jean-Marc Campagne Chem. Soc. Rev. 2009 38 2093
2. Recent examples of α-ketoglutarate-dependent mononuclear non-haem iron enzymes in natural product biosyntheses
Shu-Shan Gao,Nathchar Naowarojna,Ronghai Cheng,Xueting Liu,Pinghua Liu Nat. Prod. Rep. 2018 35 792
3. Revisiting amino acids and peptides as anti-glycation agents
H. Chilukuri,M. J. Kulkarni,M. Fernandes Med. Chem. Commun. 2018 9 614
4. Whole-cell biocatalysis for selective and productive C–O functional group introduction and modification
Manfred Schrewe,Mattijs K. Julsing,Bruno Bühler,Andreas Schmid Chem. Soc. Rev. 2013 42 6346
5. Pre-clinical pharmacokinetic and pharmacodynamic modelling study of 4-hydroxyisoleucine using validated ultra-performance liquid chromatography-tandem mass spectrometry
Geetika Wadhwa,Kowthavarapu Venkata Krishna,Rajeev Taliyan,Neeraj Tandon,Satyapal Singh Yadav,Chandrakant Katiyar,Sunil Kumar Dubey RSC Adv. 2020 10 5525
6. Pre-clinical pharmacokinetic and pharmacodynamic modelling study of 4-hydroxyisoleucine using validated ultra-performance liquid chromatography-tandem mass spectrometry
Geetika Wadhwa,Kowthavarapu Venkata Krishna,Rajeev Taliyan,Neeraj Tandon,Satyapal Singh Yadav,Chandrakant Katiyar,Sunil Kumar Dubey RSC Adv. 2020 10 5525
7. Alleviation of oxidative stress-mediated nephropathy by dietary fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) in streptozotocin-induced diabetic rats
Seetur R. Pradeep,Krishnapura Srinivasan Food Funct. 2018 9 134
8. Metabolic engineering of Zymomonas mobilis for continuous co-production of bioethanol and poly-3-hydroxybutyrate (PHB)
Yang Li,Ying Wang,Ruxiang Wang,Xiongying Yan,Jiewen Wang,Xia Wang,Shouwen Chen,Fengwu Bai,Qiaoning He,Shihui Yang Green Chem. 2022 24 2588
9. Low molecular weight galactomannans-based standardized fenugreek seed extract ameliorates high-fat diet-induced obesity in mice via modulation of FASn, IL-6, leptin, and TRIP-Br2
Amit D. Kandhare,Debasish Bandyopadhyay,Prasad A. Thakurdesai RSC Adv. 2018 8 32401
10. The first enantioselective synthesis of the amino acid, (2S,3S,4R)-γ-hydroxyisoleucine using a palladium(ii) catalysed 3,3-sigmatropic rearrangement
Andrew G. Jamieson,Andrew Sutherland,Christine L. Willis Org. Biomol. Chem. 2004 2 808

21704-86-9(4-羟基-L-异亮氨酸) 55399-93-4(4-羟基异亮氨酸) 55399-92-3(（2S，3R，4R）-2-氨基-4-羟基-3-甲基戊酸) 21704-85-8(（2S，4R）-2-氨基-4,5-二羟基-4-甲基戊酸) 105817-05-8((9ci)-4,5-二羟基-亮氨酸) 801-72-9(5,6-Epoxy-5,6-dihydroretinol acetate) 801303-33-3(N-甲氧基-N-甲基4-溴-2-氟苯甲酰胺) 801992-53-0(2,3-DIHYDRO-6,N-DIMETHYL-1H-INDEN-1-AMINE)

960化工网为您提供（2S，3R，4S）-4-羟基异亮氨酸专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.50764-07-3,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:50764-07-3 国际站:50764-07-3

50764-07-3 (（2S，3R，4S）-4-羟基异亮氨酸,(2S,3R,4S)-4-Hydroxyisoleucine)

（2S，3R，4S）-4-羟基异亮氨酸(50764-07-3)名称与标识符

名称

标识符

（2S，3R，4S）-4-羟基异亮氨酸(50764-07-3)相关文献

目录